Usefulness of SPECT/CT with a hybrid camera for the functional anatomical mapping of primary brain tumors by [Tc99m] tetrofosmin

Cancer Biotherapy and Radiopharmaceuticals

Volumn 21, Issue 1, 2006, Pages 41-48

  Filippi, Luca ^a   Schillaci, Orazio ^a,b   Santoni, Riccardo ^a   Manni, Carlo ^a   Banieli, Roberta ^a   Simonetti, Giovanni ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b NONE   (Italy)

Author keywords

Brain tumors; Functional anatomical mapping; Hybrid device; SPECT; Technetium 99m tetrofosmin

Indexed keywords

TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; BRAIN ARACHNOID CYST; BRAIN TUMOR; BRAIN VENTRICLE; CAMERA; CANCER RADIOTHERAPY; CANCER SURGERY; CAVERNOUS HEMANGIOMA; CHOROID PLEXUS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FUNCTIONAL ANATOMY; GLIOMA; HUMAN; MALE; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SINUS VENOSUS; SKULL;

ADULT; AGED; BRAIN MAPPING; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PHOTONS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33644909039     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2006.21.41     Document Type: Article

References (18)

1. Del Sole A, Falini A, Ravasi A, et al. Anatomical and biochemical investigation of primary brain tumors. Eur J Nucl Med 2001;28:1851.
2. Baldari S, Restifo Pecorella G, Cosentino S, et al. Investigation of brain tumors with (99m)Tc-MIBI SPET. Q J Nucl Med 2002;46:336.
3. Filippi L, Santoni R, Manni C, et al. Imaging primary brain tumors by single photon emission computerized tomography (SPECT) with technetium-99m sestamibi (MIBI) and tetrofosmin. Curr Med Imaging Rev 2005;1:61.
4. Soler C, Beauchesne P, Maatougui K, et al. Technetium-99m sestamibi brain single photon emission tomography for detection of recurrent gliomas after radiation therapy. Eur J Nucl Med 1998;25:1649.
5. Soricelli A, Cuocolo A, Varrone A, et al. Techetium-99m-tetrofosmin uptake in brain tumors by SPECT: Comparison with thallium-201 imaging. J Nucl Med 1998;39:802.
6. 99mTcMIBI, and 18F-fluorodeoxygluose. J Neurooncol 2000;46:63.
7. Shreve PD. Adding structures to function. J Nucl Med 2000;41:1380.
8. Cook GJ, Ott RJ. Dual-modality imaging. Eur Radiol 2001;11:1857.
9. Maintz JB, Viergever MA. A survey of medical imaging registration. Med Image Anal 1998;2:1.
10. Schillaci O, Simonetti G. Fusion imaging in nuclear medicine-applications of dual-modality systems in oncology. Cancer Biother Radiopharm 2004;19:1.
11. Schillaci O, Danieli R, Manni C, et al. Is SPECT/CT with a hybrid camera useful to improve scintigraphic imaging interpretation? Nucl Med Commun 2004;25:705.
12. Bocher M, Balan A, Krausz Y, et al. Gamma camera-mounted anatomical X-ray tomography: Technology, system characteristics, and first images. Eur J Nucl Med 2000;27:619.
13. Nelson SJ. Imaging of brain tumors after therapy. Neuro-imag Clin N Am 1999;9:801.
14. Kelly JD, Forster AM, Higley B, et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993;34:222.
15. Arbab AS, Koizumi K, Arai T, et al. Application of Tc-99m-tetrofosmin as a tumor imaging agent: Comparison with T1-201. Ann Nucl Med 1996;10:271.
16. m-sestamibi. Nucl Med Commun 1995;15:258.
17. Mongioj V, Brusa A, Loi G, at al. Accuracy evaluation of fusion of CT, MR, and spect images using commercially available software packages (SRS PLATO and IFS). Int J Radiat Oncol Biol Phys 1999;43:227.
18. Benard F, Romsa J, Hustinx R. Imaging gliomas with positron emission tomography and single photon emission tomography. Semin Nucl Med 2003;33:148.